期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 86, 期 1, 页码 28-31出版社
WILEY
DOI: 10.1038/clpt.2009.30
关键词
-
资金
- NCI NIH HHS [P01CA130818, P01 CA130818-01A1, P01 CA130818] Funding Source: Medline
Pharmacogenomics aims to use molecular genetic markers to predict treatment outcome. Indeed, within the past decade there has been a rapid emergence of pharmacogenetic tests to aid clinicians in predicting efficacy or toxicity for some drugs. Despite this major advance in therapeutic drug management, there remain challenges to the appropriate use of pharmacogenetic tests. We discuss UGT1A1 pharmacogenetic testing to illustrate the knowledge gaps impeding widespread use of pharmacogenetic tests in the clinical setting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据